PCPZ yields 20000.00% · JNJ yields 2.13%● Live data
📍 PCPZ pulled ahead of the other in Year 1
Combined, PCPZ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PCPZ + JNJ for your $10,000?
Leeward Group Holdings Inc. provides retail insurance agency and risk consulting services in the United States. The company sells various categories of insurance products to commercial, professional, and individual customers, which include property insurance relating to physical damage to property; casualty insurance relating to legal liabilities, workers' compensation, and commercial and private passenger automobile coverages; and fidelity and surety bonds. It also sells and services group and individual life, accident, disability, health, hospitalization, medical, and dental insurance products. In addition, the company provides specialty products and services to associations, industries, and businesses, which comprise umbrella insurance policies for limited service franchise hotels and motels; personal umbrella insurance for lawyers; and mobile phone insurance program for telecommunications companies, which offers coverage for the loss, theft, or accidental damage of cell phones. Further, it creates and administers risk management services, such as reinsurance brokerage. The company distributes its products through retail agencies and insurance producers, as well as insurance programs through non-affiliated insurance agencies and associations. Leeward Group Holdings Inc. is headquartered in Pennington, New Jersey.
Full PCPZ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.